Literature DB >> 2433221

Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-octulosonate region of bacterial lipopolysaccharide.

L Brade, P Kosma, B J Appelmelk, H Paulsen, H Brade.   

Abstract

Mouse monoclonal antibodies were raised against heat-killed bacteria of the Re mutant R595 of Salmonella minnesota and characterized by the passive hemolysis and passive hemolysis inhibition tests and by double immunodiffusion experiments using lipopolysaccharide (LPS) from different rough mutants of S. minnesota and synthetic antigens. The latter were copolymerization products of acrylamide with the alpha- and beta-allylglycosides of 3-deoxy-D-manno-octulosonic acid (KDO) and the alpha-2,4-linked KDO disaccharide [poly-alpha-KDO, poly-beta-KDO, and poly-(alpha-KDO)2, respectively], and sodium (3-deoxy-D-manno-octulopyranosyl)onate-(2----6)-(2-deoxy-2-[ (R)-3- hydroxytetradecanoylamino]- beta-D-glucopyranosyl)-(1----6)-(2-deoxy-2-[(R)-3-hydroxytetradecanoy lam ino]-D-glucose) [alpha-KDO-(GlcNhm)2], representing a part structure of Re LPS. One antibody (clone 20, immunoglobulin M) was found to recognize a terminal alpha-linked KDO residue, since it reacted in the passive hemolysis assay with alpha-KDO-(GlcNhm)2 and all LPS tested, it was inhibited by all synthetic antigens containing alpha-linked KDO residues, and it gave a reaction of identity with poly-alpha-KDO and poly-(alpha-KDO)2 in double immunodiffusion experiments. A second antibody (clone 25, immunoglobulin G3) was identified as specific for an alpha-2,4-linked KDO disaccharide, since it reacted in immunodiffusion exclusively with synthetic poly-(alpha-KDO)2 and not with the monosaccharide derivatives in either anomeric configuration, and it was inhibited only with poly-(alpha-KDO)2 and with LPS from S. minnesota R595 (Re) and R345 (Rb2). The reaction of this antibody with R345 LPS is attributed to the quantitative substitution with KDO disaccharide present as a side chain, which is not present in stoichiometric amounts in the other LPS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433221      PMCID: PMC260351          DOI: 10.1128/iai.55.2.462-466.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT.

Authors:  A D ELBEIN; E C HEATH
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

2.  Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.

Authors:  S E Greisman; J B DuBuy; C L Woodward
Journal:  Proc Soc Exp Biol Med       Date:  1978-07

Review 3.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

4.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

5.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

6.  Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.

Authors:  A K Ng; C L Chen; C M Chang; A Nowotny
Journal:  J Gen Microbiol       Date:  1976-05

7.  Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.

Authors:  S C Bruins; R Stumacher; M A Johns; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

8.  Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.

Authors:  A I Braude; E J Ziegler; H Douglas; J A McCutchan
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.

Authors:  M A Johns; S C Bruins; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

10.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

View more
  12 in total

1.  The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Authors:  A Lentschat; V T El-Samalouti; J Schletter; S Kusumoto; L Brade; E T Rietschel; J Gerdes; M Ernst; H Flad; A J Ulmer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].

Authors:  E T Rietschel; H Brade
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

3.  [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].

Authors:  E T Rietschel; H Brade
Journal:  Infection       Date:  1987       Impact factor: 3.553

4.  Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype.

Authors:  A Rozalski; L Brade; P Kosma; B J Appelmelk; C Krogmann; H Brade
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  3-Deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferase of Legionella pneumophila transfers two kdo residues to a structurally different lipid A precursor of Escherichia coli.

Authors:  W Brabetz; C E Schirmer; H Brade
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

6.  Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

Authors:  B J Appelmelk; Y Q An; B G Thijs; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  OpsX from Haemophilus influenzae represents a novel type of heptosyltransferase I in lipopolysaccharide biosynthesis.

Authors:  Sabine Gronow; Werner Brabetz; Buko Lindner; Helmut Brade
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

8.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Interaction of lipopolysaccharide and phospholipid in mixed membranes: solid-state 31P-NMR spectroscopic and microscopic investigations.

Authors:  Kaoru Nomura; Takehiko Inaba; Kenichi Morigaki; Klaus Brandenburg; Ulrich Seydel; Shoichi Kusumoto
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

10.  Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide.

Authors:  L Brade; O Holst; P Kosma; Y X Zhang; H Paulsen; R Krausse; H Brade
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.